New treatments for mesothelioma boost the health care market

Jan 27, 2021 | Mesothelioma

If you believe you have mesothelioma or have been diagnosed with it, something that you may be happy to hear is that the health care market for mesothelioma is improving.

What that means is that there are new changes in treatments and the creation of innovative solutions that help boost the health care market financially. Those financial changes are a direct result of better treatments being available to patients or being developed for testing. Better treatments can help you have a higher quality of life and may even assist in putting cancer into remission.

What new cancer treatments are having the biggest impact?

Some new treatments for mesothelioma that have been highlighted include:

  • Lurbinectedin, which is a medication that treats small cell lung cancer that has metastasized through the body
  • A new Phase I/II trial of TC-210, a type of gene therapy for people with advanced mesothelin-expressing cancer

A 2019 approval from the U.S. Food and Drug Administration to grant orphan drug designation to TC-210, which means that the drug may be used to treat a rare condition upon request of the sponsor.

Medicine is changing all the time, and you deserve to receive treatment

It’s true that medical science is always changing. New treatments for people with cancers of all kinds are constantly being developed and tested. 

If you’ve been dealing with mesothelioma, it’s important that you are able to seek treatment and that you have the compensation needed to pay for those therapies. Medical care is expensive, but if you have developed mesothelioma because of a past work environment or time in the military, then you may be entitled to compensation for this work-related illness.